Berlin, Germany

Jan Gogarten

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Columbia University. Active years: 2020.


% Patents Active = 100.0


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jan Gogarten: Innovator in Virome Capture Sequencing

Introduction

Jan Gogarten is a prominent inventor based in Berlin, Germany. He is known for his significant contributions to the field of virology through innovative technologies. His work focuses on the detection and characterization of viruses that affect vertebrates.

Latest Patents

Jan Gogarten holds a patent for a virome capture sequencing platform, which includes methods for designing, constructing, and utilizing this technology. The patent describes novel methods, systems, tools, and kits that enable the simultaneous detection, identification, and characterization of all viruses known or suspected to infect vertebrates. This invention, known as the virome capture sequencing platform ('VirCapSeq-VERT'), represents a significant advancement in virology research.

Career Highlights

Jan Gogarten is affiliated with Columbia University, where he continues to develop and refine his innovative technologies. His work has garnered attention for its potential impact on public health and disease prevention.

Collaborations

Jan has collaborated with notable researchers in the field, including Walter Ian Lipkin and Omar Jabado. These collaborations have further enhanced the development and application of his inventions.

Conclusion

Jan Gogarten's contributions to virology through his innovative virome capture sequencing platform highlight the importance of research and development in understanding viral infections. His work continues to pave the way for advancements in the detection and characterization of viruses.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…